1-(1-Methyl-1H-pyrazol-4-ylmethyl)-1H-pyrazol-3-ylamine, 1g

Fmoc-N-(butyl)glycine, 95.0%, 250mg

4-ETHYL-3-(METHYLSULFONYL)-4H-1,2,4-TRIAZOLE, 95.0%, 100mg

4,7,10,13-Tetraoxapentadecanoic acid, 15-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-, 2,3,4,5,6-pentafluorophenyl ester, 97%, 1g

(2,3-Dihydrobenzofuran-6-yl)methanamine, 98+%, 1g

N-(3-formylpyridin-4-yl)-2,2-dimethylpropanamide, 95.0%, 10g

4-Isopropyl-1-methyl-2-nitrobenzene, 95.0%, 100g

4-(2,5-Dimethyl-1H-pyrrol-1-yl)-3-methyl-benzoic acid, 95.0%, 5g

1-Methylcyclopropanecarboxamide, 95.0%, 250mg

(4-(Methoxycarbonyl)-3,5-dimethylphenyl)boronic acid, 95.0%, 10g

Nitrilotris(methylenephosphonic acid) (ca. 50% in water, ca. 2.2mol/L), 95.0%, 100g

3-Chloro-2,4,5,6-tetrafluorobenzotrifluoride>98.0%(GC)25g

Reagent tablets DPD No. 3 for MD100